Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NIR-II photothermal-thermoelectric effect-enhanced electrochemical sensing for dopamine detection in sweat.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Study on the Effects and Mechanisms of an <i>Ulvan</i> Derivative in NAFLD through Gut Microbiota Fermentation.

Journal of agricultural and food chemistry·2026
Same author

The immunoregulatory effect of short-chain fatty acids in type 2 diabetes mellitus.

Frontiers in nutrition·2026
Same author

A pH-sensitive nanoplatform encapsulating a lipid droplet-specific near-infrared fluorescent probe for <i>in vivo</i> imaging of carotid artery plaques in mice.

Journal of materials chemistry. B·2026
Same author

Uncompromised reinforcement: polysiloxane with 100% room-temperature self-healing and antifouling.

Materials horizons·2026
Same author

The role of ASIC2 in glioma progression: implications for prognosis and therapeutic targeting.

PeerJ·2026

Related Experiment Video

Updated: Aug 9, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K

Function of TRPC1 in modulating hepatocellular carcinoma progression.

Huimin Qi1, Fengming Wu2, Hongmei Wang3

  • 1School of Basic Medicine, Weifang Medical University, Weifang, 261053, China.

Medical Oncology (Northwood, London, England)
|February 16, 2023
PubMed
Summary

Transient receptor potential cation channel subfamily C member 1 (TRPC1) is overexpressed in liver cancer, acting as a risk factor. Higher TRPC1 levels correlate with poorer survival, suggesting its role in promoting hepatocellular carcinoma progression.

Keywords:
Liver cancerMetabolismPrognosisTRPTRPC1

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

495
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.4K

Related Experiment Videos

Last Updated: Aug 9, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K
In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

495
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Liver cancer, particularly hepatocellular carcinoma (HCC), is a leading cause of cancer death globally.
  • Understanding the molecular mechanisms driving HCC is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of Transient Receptor Potential Cation Channel subfamily C member 1 (TRPC1) in the development and progression of liver cancer.
  • To identify TRPC1 as a potential biomarker and therapeutic target for HCC.

Main Methods:

  • Bioinformatic analysis utilizing The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases.
  • Correlation analysis between TRPC1 expression levels and patient survival outcomes (Overall Survival - OS).
  • Functional analysis of TRPC1's impact on tumor-associated signaling pathways and gene expression.

Main Results:

  • TRPC1 is significantly overexpressed in hepatocellular carcinoma tissues compared to normal liver tissues.
  • Elevated TRPC1 expression is associated with significantly worse overall survival (OS) and lower survival rates in HCC patients.
  • TRPC1 acts as an independent risk factor for overall survival in HCC.
  • TRPC1 may promote liver cancer by upregulating tumor proliferation pathways and downregulating retinol metabolism.
  • TRPC1 influences the expression of key genes including ABI2, MAPRE1, YEATS2, MTA3, TMEM237, MTMR2, CCDC6, AC069544.2, and NCBP2.

Conclusions:

  • TRPC1 plays a critical role in the pathogenesis of liver cancer and is a valuable prognostic marker.
  • Targeting TRPC1 may offer a novel therapeutic strategy for hepatocellular carcinoma.